Appropriate ethics review is required.

Healthc Manage Forum

1 A pRoject Ethics Community Consensus Initiative, Alberta Innovates-Health Solutions, Edmonton, Alberta, Canada.

Published: January 2017

AI Article Synopsis

Article Abstract

Health leaders manage many types of risk. One type of risk that may be underrecognized is the ethical risk in the many projects and activities that are done regularly besides research (eg, program evaluation, quality improvement, and health innovation). Applying clinical, personal, professional, and organizational ethics can help address the risks but are insufficient by themselves or in combination. Each different type of project or activity requires an ethics review that is appropriate for that activity. Health leaders must first acknowledge that ethical risks exist in many of the activities occurring in their organization and then support the different types of ethics review required to adequately protect and respect people and their information.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0840470416669926DOI Listing

Publication Analysis

Top Keywords

ethics review
12
review required
8
health leaders
8
appropriate ethics
4
required health
4
leaders manage
4
manage types
4
types risk
4
risk type
4
type risk
4

Similar Publications

We appreciate Reierson's thoughtful commentary on our 2019 paper, which described our experiences, ethical process, judgment calls, and lessons from a 2016-2017 data-sharing pilot between Crisis Text Line and academic researchers. The commentary raises important questions about the ethical conduct of health research in the digital age, particularly regarding informed consent, potential conflicts of interest, and the protection of vulnerable populations. Our article focused specifically on the noncommercial use of Crisis Text Line data for research purposes, so we restrict our reply to points relevant to such usage.

View Article and Find Full Text PDF

Background: Many studies have validated the use of antiplatelet or anticoagulant therapy in coronary artery ectasia (CAE) to reduce major adverse cardiovascular events (MACE); however, it is not completely known which group of these antithrombotic medications is more effective. The purpose of this systematic review and network meta-analysis was to evaluate the efficacy of different anti-thrombotic treatments in adult patients with CAE.

Methods: This systematic review and meta-analysis followed preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines as well as PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses and adhered to a registered predetermined methodology noted in the prospective register of systematic reviews (PROSPERO) protocol.

View Article and Find Full Text PDF

Parkinson's disease (PD) is characterized by motor and non-motor symptoms, including olfactory dysfunction. Prior studies have shown that olfaction deteriorates with disease progression, however fluctuations in olfaction and related PD symptoms have been less explored. This study aimed to investigate correlations between changes in odor identification ability and PD symptoms.

View Article and Find Full Text PDF

Capillary refill time paradoxically decreases in a blood loss shock model.

Intensive Care Med Exp

January 2025

Department of Emergency Medicine in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, 582 25, Linköping, Sweden.

Background: This study aimed to investigate whether changes in capillary refill (CR) time precede macrovascular signs of deterioration in a human model of blood loss shock. The study was conducted at the Department of Emergency Medicine in Linköping, Sweden, and involved 42 healthy volunteers aged 18-45. Participants were randomized into two provocations of applied lower body negative pressure (LBNP): a stepwise escalation protocol and a direct application protocol, to simulate gradual and acute blood loss.

View Article and Find Full Text PDF

Hypertension, dyslipidemia, and type 2 diabetes are highly prevalent and poorly controlled cardiometabolic diseases in the Middle East. Therapeutic non-adherence and therapeutic inertia are major contributors to this suboptimal disease control. Regardless of the cardiometabolic disease, evidence-based solutions may be used to improve therapeutic non-adherence and overcome inertia, and thereby help to alleviate the heavy burden of cardiovascular disease in the Middle East.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!